Xtant Medical is shedding side businesses to focus on its higher-value biologic products used in spine surgery and wound care, betting that a bigger sales team and more in-house manufacturing will drive stronger profits over time. The key question is whether new products and hospital demand can offset lost revenue from the divestiture and hold up as reimbursement rules shift.Read more
Xtant Medical is leaning into higher-value surgical products and a newly added bleeding-control product, betting its expanded sales team can open doors to more hospitals and procedures. The upside looks real if adoption ramps up, but big rivals, rising selling costs, and shifting insurance reimbursement could trip up the plan.Read more
Xtant Medical is trying to grow by widening its product line and building a bigger hospital sales team, but the transition could be messy and keep profits under pressure. The key question is whether new product launches and a broader push into hospitals can outpace reimbursement and pricing headwinds in wound care and other biologics.Read more
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.
